Organoids as preclinical platforms for metabolic dysfunction-associated steatotic liver disease: Model construction, mechanistic dissection, and therapeutic translation
World Journal of Gastroenterology · 28.12.2026 · 32 (48)
DOI: 10.3748/wjg.123934 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 28.12.2026. Verfasst von Hao-Yu Xue und 3 weiteren Autor:innen. Die Arbeit nennt 95 Literaturangaben.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a global public health challenge, necessitating reliable in vitro models to unravel its complex pathophysiology and accelerate therapeutic development. Organoid systems have revolutionized MASLD research by recapitulating key hepatic structural features, cellular heterogeneity, and pathological processes. This review systematically summarizes liver organoids derived from human pluripotent stem cells, primary tissues, and immortalized cell lines in MASLD research, highlighting their distinct advantages in modeling MASLD pathogenesis, elucidating mechanisms, screening biomarkers, and validating therapeutics. In addition, we elaborate on the progress gained from multi-tissue organoid systems in deciphering inter-organ crosstalk and systemic metabolic perturbations associated with MASLD. We further discuss the inherent limitations of current organoid models and propose future directions for their development. Collectively, this review highlights the indispensable role of organoid models in unraveling the complex molecular mechanisms of MASLD, in advancing drug discovery, and in identifying diagnostic biomarkers, while also providing insights to accelerate their clinical translation toward precision medicine for MASLD.
Zitieren
APA
Xue, H., Ren, T., Pan, Q., & Fan, J. (2026). Organoids as preclinical platforms for metabolic dysfunction-associated steatotic liver disease: Model construction, mechanistic dissection, and therapeutic translation. World Journal of Gastroenterology, 32(48). https://doi.org/10.3748/wjg.123934
Vancouver
Xue H, Ren T, Pan Q, Fan J. Organoids as preclinical platforms for metabolic dysfunction-associated steatotic liver disease: Model construction, mechanistic dissection, and therapeutic translation. World Journal of Gastroenterology. 2026;32(48). doi:10.3748/wjg.123934
BibTeX
@article{Xue2026,
author = {Xue, Hao-Yu and Ren, Tian-Yi and Pan, Qin and Fan, Jian-Gao},
title = {Organoids as preclinical platforms for metabolic dysfunction-associated steatotic liver disease: Model construction, mechanistic dissection, and therapeutic translation},
journal = {World Journal of Gastroenterology},
year = {2026},
volume = {32},
number = {48},
doi = {10.3748/wjg.123934}
}
EUVIMED